Intrinsic ANG II type 1 receptor stimulation contributes to recovery of postischemic mechanical function

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 274, Issue 5 43-5, 1998, Pages

  Ford, William R ^a   Clanachan, Alexander S ^a   Lopaschuk, Gary D ^a   Schulz, Richard ^a   Jugdutt, Bodh I ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cardioprotection; Glucose metabolism; Proton production

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CYCLOHEXYLADENOSINE; GLUCOSE; INSULIN; LOSARTAN; PALMITIC ACID; PROTON;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GLUCOSE METABOLISM; GLYCOLYSIS; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0031861631     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1998.274.5.h1524     Document Type: Article

References (30)

1. Asimakis, G. K., K. Inners McBride, G. Medellin, and V. R. Conti. Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H887-H894, 1992.
2. Booz, G. W., and K. M. Baker. Role of type 1 and type 2 angiotensin receptors in angiotensin H-induced cardiomyocyte hypertrophy. Hypertension 28: 635-640, 1996.
3. Christ, D. D. Human plasma protein binding of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) and its pharmacologically active metabolite EXP3174. J. Clin. Pharmacol. 35: 515-520, 1995.
4. Davies, B., and T. Morris. Physiological parameters in labora tory animals and humans. Pharm. Res. 10: 1093-1095, 1993.
5. De Leiris, J., D. Harding, and S. Pestre. The isolated perfused heart: a model for studying myocardial hypoxia or ischemia. Basic Res. Cardiol. 79: 313-321, 1984.
6. Dennis, S. C., W. Gevers, and L. H. Opie. Protons in ischemia: where do they come from; where do they go to? J. Mol. Cell. Cardiol. 23: 1077-1086, 1991.
7. Dudley, D. T., R. L. Panek, T. C. Major, G. H. Lu, R. F. Bruns, B. A. Klinkefus, J. C. Hodges, and R. E. Weishaar. Subclasses of angiotensin II binding sites and their functional significance. Mol. Pharmacol. 38: 370-377, 1990.
8. Finegan, B. A., G. D. Lopaschuk, C. S. Coulson, and A. S. Clanachan. Adenosine alters glucose use during ischemia and reperfusion in isolated rat hearts. Circulation 87: 900-908, 1993.
9. Finegan, B. A., A. S. Clanachan, C. S. Coulson, and G. D. Lopaschuk. Adenosine modification of energy substrate use in isolated working hearts perfused with fatty acids. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H1501-H1507, 1992.
10. 1 receptor stimulation during reperfusion following ischaemia. Br. J. Pharmacol. 118: 355-363, 1996.
11. 2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts. Circulation 94: 3087-3089, 1996.
12. Galinanes, M., and D. J. Hearse. Assessment of ischemic injury and protective interventions: the Langendorff versus the working rat heart preparation. Can. J. Cardiol. 6: 83-91, 1990.
13. 1 stimulation activates δ-protein kinase C in rat ventricular myocytes. Circ. Res. 78: 161-165, 1996.
14. Hunyady, L, T. Balla, and K. Catt. The ligand binding site of the angiotensin ATi receptor. Trends Pharmacol. Sci. 17: 135-140, 1996.
15. Ishihata, A., and M. Endoh. Species-related differences in inotropic effects of angiotensin II in mammalian ventricular muscle: receptors, subtypes and phosphoinositide hydrolysis. Br. J. Pharmacol. 114: 447-453, 1995.
16. 2+ channel current by angiotensin II in rabbit ventricular myocytes. Circ. Res. 75: 1121-1125, 1994.
17. Li, Y., and R. A. Kloner. Does protein kinase C play a role in ischemic preconditioning in rat hearts? Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H426-H431, 1995.
18. Liu, B., A. S. Clanachan, R. Schulz, and G. D. Lopaschuk. Cardiac efficiency is improved following ischemia by altering both the source and the fate of protons. Circ. Res. 79: 940-948, 1996.
19. Liu, Y., A. Tsuchida, M. V. Cohen, and J. M. Downey. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J. Mol. Cell. Cardiol. 27: 883-892, 1995.
20. Neely, J. R., H. Liebermeister, E. J. Battersby, and H. E. Morgan. Effect of pressure development on oxygen consumption by isolated rat heart. Am. J. Physiol. 212: 804-814, 1967.
21. Regitz-Zagrosek, V., N. Friedel, A. Heymann, P. Bauer, M. Neuss, A. Rolfs, C. Steffen, A. Hildebrandt, R. Hetzer, and E. Fleck. Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation 91: 1461-1471, 1995.
22. Ruzicka, M., V. Skarda, B. Yuan, J. Rosenthal, and F. H. H. Leenan. Changes in plasma and cardiac angiotensin II in response to acute myocardial infarction in rats (Abstract). Circulation 92, Suppl. I: I-454, 1995.
23. Schieffer, B., A. Wirger, M. Meybrunn, S. Seitz, J. Holtz, U. N. Riede, and H. Drexler. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 89: 2273-2282, 1994.
24. Sun, Y., and K. T. Weber. Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc. Res. 28: 1623-1628, 1994.
25. + overload and depressed recovery of ventricular function of reper fused ischemic rat hearts. Circ. Res. 65: 1045-1056, 1989.
26. 1-selective adenosine analogues protects the heart against infarction. Circulation 85: 659-665, 1992.
27. Timmermans, P. B., and R. D. Smith. Angiotensin II receptor subtypes: selective antagonists and functional correlates. Eur. Heart J. 15: 79-87, 1994.
28. Wong, P. C., S. D. Hart, J. V. Duncia, and P. B. Timmermans. Nonpeptide angiotensin II receptor antagonists. Studies with DuP 753 and EXP3174 in dogs. Eur. J. Pharmacol. 202: 323-330, 1991.
29. Yoshiyama, M., S. Kim, H. Yamagishi, T. Omura, T. Tani, M. Takagi, I. Toda, M. Teragaki, K. Akioka, K. Takeuchi, and T. Takeda. The deleterious effects of exogenous angiotensin I and angiotensin II on myocardial ischemia-reperfusion injury. Jpn. Circ. J. 58: 362-368, 1994.
30. Yoshiyama, M., S. Kim, H. Yamagishi, T. Omura, T. Tani, S. Yanagi, I. Toda, M. Teragaki, K. Akioka, K. Takeuchi, and T. Takeda. Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury. Am. Heart J. 128: 1-6, 1994.